Edition:
India

Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

4.04USD
2 Dec 2020
Change (% chg)

$-0.01 (-0.25%)
Prev Close
$4.05
Open
$4.05
Day's High
$4.11
Day's Low
$3.97
Volume
229,742
Avg. Vol
262,695
52-wk High
$5.78
52-wk Low
$2.40

Latest Key Developments (Source: Significant Developments)

Phathom Pharmaceuticals Announces Appointment Of Todd Branning As CFO
Monday, 13 Jul 2020 

July 13 (Reuters) - Phathom Pharmaceuticals Inc ::PHATHOM PHARMACEUTICALS ANNOUNCES APPOINTMENT OF TODD BRANNING AS CHIEF FINANCIAL OFFICER.PHATHOM PHARMACEUTICALS - INTERIM CFO, DAVID SOCKS, WILL CONTINUE WITH CO AS A STRATEGIC ADVISOR AND REMAIN A MEMBER OF BOARD.PHATHOM PHARMACEUTICALS - BRANNING WAS MOST RECENTLY WITH AMNEAL PHARMACEUTICALS WHERE HE SERVED AS CFO.  Full Article

Alkermes Announces Settlement With Amneal Over Vivitrol Patent Dispute
Monday, 29 Jul 2019 

July 29 (Reuters) - Alkermes Plc ::ALKERMES ANNOUNCES SETTLEMENT WITH AMNEAL OVER VIVITROL® PATENT DISPUTE.ALKERMES PLC - PATENT TRIAL AND APPEAL BOARD ORAL HEARING CANCELLED.ALKERMES PLC - ADDITIONAL TERMS OF AGREEMENT ARE CONFIDENTIAL.ALKERMES - ENTERED INTO SETTLEMENT WITH AMNEAL PHARMA TO RESOLVE AMNEAL'S INTER PARTES REVIEW PETITION CHALLENGING U.S. PATENT NUMBER 7,919,499.  Full Article

Amneal Announces Agreement With Zentiva To Divest Creo Pharma
Monday, 1 Apr 2019 

April 1 (Reuters) - Amneal Pharmaceuticals Inc ::PRESS RELEASE - AMNEAL ANNOUNCES AGREEMENT WITH ZENTIVA TO DIVEST CREO PHARMA.AMNEAL PHARMACEUTICALS INC - ZENTIVA HAS ACQUIRED CREO PHARMACEUTICALS.  Full Article

Amneal Pharmaceuticals Inc Files For Potential Mixed Shelf Offering Size Not Disclosed - SEC Filing
Saturday, 2 Mar 2019 

March 1 (Reuters) - Amneal Pharmaceuticals Inc ::AMNEAL PHARMACEUTICALS INC FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING.  Full Article